JE Cleantech Holdings Limited (NASDAQ:JCSE) Short Interest Down 25.6% in December
by Danessa Lincoln · The Markets DailyJE Cleantech Holdings Limited (NASDAQ:JCSE – Get Free Report) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totaling 259 shares, a decline of 25.6% from the November 30th total of 348 shares. Based on an average daily volume of 2,295 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 2,295 shares, the days-to-cover ratio is presently 0.1 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of JE Cleantech in a research report on Monday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.
Get Our Latest Research Report on JCSE
JE Cleantech Stock Performance
Shares of NASDAQ JCSE opened at $1.05 on Thursday. The firm’s 50 day moving average price is $1.17 and its 200-day moving average price is $1.14. JE Cleantech has a 52-week low of $0.86 and a 52-week high of $1.75. The company has a current ratio of 2.58, a quick ratio of 1.11 and a debt-to-equity ratio of 0.49.
About JE Cleantech
JE Cleantech Holdings Ltd. is an Israel-based environmental technology firm specializing in advanced water and wastewater treatment solutions. The company designs, manufactures and markets a suite of modular treatment systems that integrate proprietary membrane filtration, advanced oxidation processes, biological treatment and customized chemical formulations. Its offerings address water purification, recycling and process water challenges across municipal, industrial and agricultural end markets.
Through a combination of standardized equipment platforms and bespoke engineering services, JE Cleantech helps clients meet stringent regulatory requirements, reduce freshwater intake and lower overall treatment costs.